vp-315
Generic: ruxotemitide·Code: VP-315
vp-315: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | Phase 2 |
Get deeper analysis on vp-315
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis